Ratings by Citizens (Silvan Tuerkcan)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/23/2026 | Taysha Gene Therapies | TSHA | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 6/12/2026 | CRISPR Therapeutics | CRSP | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 5/27/2026 | CRISPR Therapeutics | CRSP | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 5/14/2026 | Acrivon Therapeutics Inc | ACRV | Maintain | Market Outperform (N/A) |
|
Details | ||
| 4/14/2026 | Cellectis | CLLS | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 3/26/2026 | Terns Pharmaceuticals | TERN | Downgrade | Market Perform (Market Outperform) |
50.00 (52.95) |
5.9% | Details | |
| 3/24/2026 | Acrivon Therapeutics Inc | ACRV | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 3/23/2026 | Cellectis | CLLS | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 3/17/2026 | Foghorn Therapeutics | FHTX | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 1/30/2026 | CRISPR Therapeutics | CRSP | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 1/14/2026 | Exelixis | EXEL | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 1/13/2026 | Nuvation Bio Inc | NUVB | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 1/13/2026 | Benitec BioPharma | BNTC | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 12/18/2025 | Exelixis | EXEL | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 12/17/2025 | Solid Biosciences | SLDB | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 12/17/2025 | Taysha Gene Therapies | TSHA | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 12/17/2025 | Generation Bio | GBIO | Maintain | Market Perform (Market Perform) |
|
Details | ||
| 12/11/2025 | Terns Pharmaceuticals | TERN | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 12/8/2025 | CRISPR Therapeutics | CRSP | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 12/3/2025 | Jasper Therapeutics | JSPR | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 11/26/2025 | Terns Pharmaceuticals | TERN | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 11/20/2025 | Nuvation Bio Inc | NUVB | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 11/18/2025 | Relay Therapeutics | RLAY | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 11/18/2025 | Cellectis | CLLS | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 11/18/2025 | Benitec BioPharma | BNTC | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 11/17/2025 | Acrivon Therapeutics Inc | ACRV | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 11/12/2025 | Engene Holdings Inc. | ENGN | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 11/11/2025 | CRISPR Therapeutics | CRSP | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 11/10/2025 | Context Therapeutics | CNTX | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 11/5/2025 | Taysha Gene Therapies | TSHA | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 11/4/2025 | Nuvation Bio Inc | NUVB | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 11/4/2025 | Benitec BioPharma | BNTC | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 10/28/2025 | Intellia Therapeutics | NTLA | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 10/23/2025 | Terns Pharmaceuticals | TERN | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 10/21/2025 | Exelixis | EXEL | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 10/13/2025 | Taysha Gene Therapies | TSHA | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 10/13/2025 | Ideaya Biosciences | IDYA | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 10/13/2025 | CRISPR Therapeutics | CRSP | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 10/8/2025 | Terns Pharmaceuticals | TERN | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 10/7/2025 | Ideaya Biosciences | IDYA | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 10/6/2025 | Intellia Therapeutics | NTLA | Upgrade | Market Outperform (Market Perform) |
20.44 (15.50) |
-24.17% | Details | |
| 9/24/2025 | Benitec BioPharma | BNTC | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 9/22/2025 | Jasper Therapeutics | JSPR | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 9/19/2025 | Intellia Therapeutics | NTLA | Maintain | Market Perform (Market Perform) |
|
Details | ||
| 9/17/2025 | Acrivon Therapeutics Inc | ACRV | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 9/12/2025 | Taysha Gene Therapies | TSHA | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 9/12/2025 | Solid Biosciences | SLDB | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 9/12/2025 | Benitec BioPharma | BNTC | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 9/9/2025 | Ideaya Biosciences | IDYA | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 9/8/2025 | Ideaya Biosciences | IDYA | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 9/4/2025 | Ideaya Biosciences | IDYA | New Coverage | Market Outperform (N/A) |
25.48 (36.28) |
42.39% | Details | |
| 8/15/2025 | MacroGenics | MGNX | Maintain | Market Perform (Market Perform) |
|
Details | ||
| 8/15/2025 | Acrivon Therapeutics Inc | ACRV | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 8/14/2025 | Solid Biosciences | SLDB | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 8/14/2025 | Jasper Therapeutics | JSPR | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 8/14/2025 | Generation Bio | GBIO | Maintain | Market Perform (Market Perform) |
|
Details | ||
| 7/29/2025 | Exelixis | EXEL | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 7/24/2025 | Exelixis | EXEL | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 7/21/2025 | Solid Biosciences | SLDB | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 7/21/2025 | Prime Medicine | PRME | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 7/10/2025 | Jasper Therapeutics | JSPR | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 7/10/2025 | Benitec BioPharma | BNTC | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 7/8/2025 | Jasper Therapeutics | JSPR | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 6/27/2025 | CRISPR Therapeutics | CRSP | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 6/25/2025 | Nuvation Bio Inc | NUVB | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 6/23/2025 | Exelixis | EXEL | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 6/18/2025 | Prime Medicine | PRME | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 6/18/2025 | CRISPR Therapeutics | CRSP | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 6/17/2025 | Terns Pharmaceuticals | TERN | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 6/17/2025 | Intellia Therapeutics | NTLA | Maintain | Market Perform (Market Perform) |
|
Details | ||
| 6/16/2025 | Jasper Therapeutics | JSPR | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 6/16/2025 | Engene Holdings Inc. | ENGN | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 6/13/2025 | Nuvation Bio Inc | NUVB | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 6/12/2025 | Nuvation Bio Inc | NUVB | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 6/11/2025 | MacroGenics | MGNX | Maintain | Market Perform (Market Perform) |
|
Details | ||
| 6/10/2025 | Elevation Oncology | ELEV | Maintain | Market Perform (Market Perform) |
|
Details | ||
| 6/3/2025 | Relay Therapeutics | RLAY | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 6/3/2025 | Exelixis | EXEL | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 6/3/2025 | Context Therapeutics | CNTX | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 6/2/2025 | Nuvation Bio Inc | NUVB | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 5/29/2025 | Taysha Gene Therapies | TSHA | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 5/29/2025 | Intellia Therapeutics | NTLA | Maintain | Market Perform (Market Perform) |
|
Details | ||
| 5/21/2025 | CRISPR Therapeutics | CRSP | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 5/20/2025 | Prime Medicine | PRME | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 5/16/2025 | Solid Biosciences | SLDB | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 5/15/2025 | Foghorn Therapeutics | FHTX | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 5/15/2025 | Benitec BioPharma | BNTC | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 5/14/2025 | Exelixis | EXEL | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 5/9/2025 | Vor Biopharma, Inc. | VOR | Downgrade | Market Perform (Market Outperform) |
0.54 (14.48) |
2581.48% | Details | |
| 5/7/2025 | CRISPR Therapeutics | CRSP | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 4/30/2025 | Foghorn Therapeutics | FHTX | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 4/29/2025 | Engene Holdings Inc. | ENGN | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 4/28/2025 | Taysha Gene Therapies | TSHA | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 4/23/2025 | Nuvation Bio Inc | NUVB | New Coverage | Market Outperform (N/A) |
1.98 (6.46) |
226.26% | Details | |
| 4/23/2025 | Foghorn Therapeutics | FHTX | New Coverage | Market Outperform (N/A) |
3.90 (4.08) |
4.62% | Details | |
| 4/21/2025 | Terns Pharmaceuticals | TERN | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 4/17/2025 | Exelixis | EXEL | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 4/10/2025 | Benitec BioPharma | BNTC | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 3/26/2025 | Acrivon Therapeutics Inc | ACRV | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 3/24/2025 | Vor Biopharma, Inc. | VOR | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 3/24/2025 | Context Therapeutics | CNTX | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 3/24/2025 | Acrivon Therapeutics Inc | ACRV | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 3/21/2025 | MacroGenics | MGNX | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 3/21/2025 | Elevation Oncology | ELEV | Downgrade | Market Perform (Market Outperform) |
0.48 (0.37) |
-22.92% | Details | |
| 3/19/2025 | Prime Medicine | PRME | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 3/18/2025 | Benitec BioPharma | BNTC | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 3/14/2025 | Generation Bio | GBIO | Maintain | Market Perform (Market Perform) |
|
Details | ||
| 3/10/2025 | Elevation Oncology | ELEV | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 3/7/2025 | Solid Biosciences | SLDB | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 3/4/2025 | Prime Medicine | PRME | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 2/28/2025 | Relay Therapeutics | RLAY | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 2/19/2025 | Solid Biosciences | SLDB | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 2/19/2025 | Benitec BioPharma | BNTC | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 2/18/2025 | Jasper Therapeutics | JSPR | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 2/12/2025 | Exelixis | EXEL | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 2/5/2025 | Solid Biosciences | SLDB | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 1/27/2025 | Exelixis | EXEL | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 1/23/2025 | Exelixis | EXEL | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 1/15/2025 | Exelixis | EXEL | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 1/8/2025 | Context Therapeutics | CNTX | New Coverage | Market Outperform (N/A) |
1.17 (0.58) |
-50.43% | Details | |
| 12/30/2024 | Vor Biopharma, Inc. | VOR | Maintain | Market Outperform (N/A) |
|
Details | ||
| 12/10/2024 | Solid Biosciences | SLDB | New Coverage | Market Outperform (N/A) |
5.05 (9.25) |
83.17% | Details | |
| 12/10/2024 | Prime Medicine | PRME | New Coverage | Market Outperform (N/A) |
3.27 (3.12) |
-4.59% | Details | |
| 11/18/2024 | Engene Holdings Inc. | ENGN | New Coverage | Market Outperform (N/A) |
7.93 (8.85) |
11.6% | Details | |
| 11/7/2024 | MacroGenics | MGNX | Downgrade | Market Perform (Market Outperform) |
3.77 (4.78) |
26.79% | Details | |
| 10/16/2024 | Exelixis | EXEL | Maintain | Market Outperform (N/A) |
|
Details | ||
| 10/14/2024 | Benitec BioPharma | BNTC | Maintain | Market Outperform (N/A) |
|
Details | ||
| 9/20/2024 | Notable Labs, Inc. | NTBL | Downgrade | Market Perform (Market Outperform) |
0.45 (0.25) |
-44.44% | Details | |
| 9/10/2024 | Terns Pharmaceuticals | TERN | Maintain | Market Outperform (N/A) |
|
Details | ||
| 9/9/2024 | Jasper Therapeutics | JSPR | New Coverage | Market Outperform (N/A) |
19.15 (0.49) |
-97.44% | Details | |
| 8/7/2024 | Exelixis | EXEL | Maintain | Market Outperform (N/A) |
|
Details | ||
| 7/31/2024 | MacroGenics | MGNX | Maintain | Market Outperform (N/A) |
|
Details | ||
| 7/18/2024 | Relay Therapeutics | RLAY | Maintain | Market Outperform (N/A) |
|
Details | ||
| 5/10/2024 | MacroGenics | MGNX | Maintain | Market Outperform (N/A) |
|
Details | ||
| 4/25/2024 | Acrivon Therapeutics Inc | ACRV | Maintain | Market Outperform (N/A) |
|
Details | ||
| 4/22/2024 | Benitec BioPharma | BNTC | Maintain | Market Outperform (N/A) |
|
Details | ||
| 3/18/2024 | Terns Pharmaceuticals | TERN | Maintain | Market Outperform (N/A) |
|
Details | ||
| 3/11/2024 | MacroGenics | MGNX | Maintain | Market Outperform (N/A) |
|
Details | ||
| 3/1/2024 | Acrivon Therapeutics Inc | ACRV | New Coverage | Market Outperform (N/A) |
4.47 (1.62) |
-63.76% | Details | |
| 3/1/2024 | Elevation Oncology | ELEV | New Coverage | Market Outperform (N/A) |
3.85 (0.48) |
-87.53% | Details | |
| 2/15/2024 | Benitec BioPharma | BNTC | Maintain | Market Outperform (N/A) |
|
Details | ||
| 2/13/2024 | CRISPR Therapeutics | CRSP | Maintain | Market Outperform (N/A) |
|
Details | ||
| 1/24/2024 | Benitec BioPharma | BNTC | Maintain | Market Outperform (N/A) |
|
Details | ||
| 1/24/2024 | MacroGenics | MGNX | Maintain | Market Outperform (N/A) |
|
Details | ||
| 12/19/2023 | Notable Labs, Inc. | NTBL | Maintain | Market Outperform (N/A) |
|
Details | ||
| 12/11/2023 | CRISPR Therapeutics | CRSP | Maintain | Market Outperform (N/A) |
|
Details | ||
| 10/23/2023 | Generation Bio | GBIO | Downgrade | Market Perform (Market Outperform) |
1.20 (5.34) |
345% | Details | |
| 10/18/2023 | Notable Labs, Inc. | NTBL | New Coverage | Market Outperform (N/A) |
4.35 (0.45) |
-89.66% | Details | |
| 10/9/2023 | Mirati Therapeutics | MRTX | Downgrade | Market Perform (Market Outperform) |
62.38 (58.70) |
-5.9% | Details | |
| 10/6/2023 | Mirati Therapeutics | MRTX | Maintain | Market Outperform (N/A) |
|
Details | ||
| 9/26/2023 | Benitec BioPharma | BNTC | Maintain | Market Outperform (N/A) |
|
Details | ||
| 8/21/2023 | Exelixis | EXEL | Maintain | Market Outperform (N/A) |
|
Details | ||
| 6/9/2023 | CRISPR Therapeutics | CRSP | Maintain | Market Outperform (N/A) |
|
Details | ||
| 5/11/2023 | MacroGenics | MGNX | Maintain | Market Outperform (N/A) |
|
Details | ||
| 5/5/2023 | Relay Therapeutics | RLAY | Maintain | Market Outperform (N/A) |
|
Details | ||
| 2/14/2023 | Terns Pharmaceuticals | TERN | New Coverage | Market Outperform (N/A) |
9.83 (50.00) |
408.65% | Details | |
| 2/1/2023 | Taysha Gene Therapies | TSHA | Maintain | Market Outperform (N/A) |
|
Details | ||
| 1/19/2023 | Vor Biopharma, Inc. | VOR | Maintain | Market Outperform (N/A) |
|
Details | ||
| 1/19/2023 | Taysha Gene Therapies | TSHA | Maintain | Market Outperform (N/A) |
|
Details | ||
| 1/19/2023 | Relay Therapeutics | RLAY | Maintain | Market Outperform (N/A) |
|
Details | ||
| 1/19/2023 | Intellia Therapeutics | NTLA | Downgrade | Market Perform (Market Outperform) |
37.05 (20.44) |
-44.83% | Details | |
| 1/19/2023 | MacroGenics | MGNX | Maintain | Market Outperform (N/A) |
|
Details | ||
| 1/19/2023 | Generation Bio | GBIO | Maintain | Market Outperform (N/A) |
|
Details | ||
| 1/19/2023 | Exelixis | EXEL | Maintain | Market Outperform (N/A) |
|
Details | ||
| 1/19/2023 | CRISPR Therapeutics | CRSP | Maintain | Market Outperform (N/A) |
|
Details | ||
| 1/19/2023 | Cellectis | CLLS | Maintain | Market Outperform (N/A) |
|
Details | ||
| 11/10/2022 | Taysha Gene Therapies | TSHA | Maintain | Market Outperform (N/A) |
|
Details | ||
| 10/18/2022 | Exelixis | EXEL | New Coverage | Market Outperform (N/A) |
15.65 (52.87) |
237.83% | Details | |
| 10/18/2022 | Benitec BioPharma | BNTC | New Coverage | Market Outperform (N/A) |
0.24 (13.63) |
5579.17% | Details | |
| 9/19/2022 | Intellia Therapeutics | NTLA | Maintain | Market Outperform (N/A) |
|
Details | ||
| 9/14/2022 | Relay Therapeutics | RLAY | Maintain | Market Outperform (N/A) |
|
Details | ||
| 8/16/2022 | LogicBio Therapeutics | LOGC | Maintain | Market Outperform (N/A) |
|
Details | ||
| 8/8/2022 | Mirati Therapeutics | MRTX | Maintain | Market Outperform (N/A) |
|
Details | ||
| 8/8/2022 | Generation Bio | GBIO | Maintain | Market Outperform (N/A) |
|
Details | ||
| 8/5/2022 | Intellia Therapeutics | NTLA | Maintain | Market Outperform (N/A) |
|
Details | ||
| 8/4/2022 | Mirati Therapeutics | MRTX | Maintain | Market Outperform (N/A) |
|
Details | ||
| 7/12/2022 | MacroGenics | MGNX | Maintain | Market Outperform (N/A) |
|
Details | ||
| 6/7/2022 | Mirati Therapeutics | MRTX | Upgrade | Market Outperform (Market Perform) |
44.33 (58.70) |
32.42% | Details | |
| 5/17/2022 | Taysha Gene Therapies | TSHA | Maintain | Market Outperform (N/A) |
|
Details | ||
| 5/13/2022 | Vor Biopharma, Inc. | VOR | Maintain | Market Outperform (N/A) |
|
Details | ||
| 5/11/2022 | CRISPR Therapeutics | CRSP | Maintain | Market Outperform (N/A) |
|
Details | ||
| 5/10/2022 | LogicBio Therapeutics | LOGC | Maintain | Market Outperform (N/A) |
|
Details | ||
| 5/9/2022 | Relay Therapeutics | RLAY | Maintain | Market Outperform (N/A) |
|
Details | ||
| 5/9/2022 | Intellia Therapeutics | NTLA | Maintain | Market Outperform (N/A) |
|
Details | ||
| 4/1/2022 | Taysha Gene Therapies | TSHA | Maintain | Market Outperform (N/A) |
|
Details | ||
| 3/16/2022 | Vor Biopharma, Inc. | VOR | Maintain | Market Outperform (N/A) |
|
Details | ||
| 2/28/2022 | MacroGenics | MGNX | Maintain | Market Outperform (N/A) |
|
Details | ||
| 2/16/2022 | CRISPR Therapeutics | CRSP | Maintain | Market Outperform (N/A) |
|
Details | ||
| 2/11/2022 | CRISPR Therapeutics | CRSP | Maintain | Market Outperform (N/A) |
|
Details | ||
| 2/3/2022 | LogicBio Therapeutics | LOGC | Maintain | Market Outperform (N/A) |
|
Details | ||
| 1/27/2022 | Taysha Gene Therapies | TSHA | Maintain | Market Outperform (N/A) |
|
Details | ||
| 1/7/2022 | Intellia Therapeutics | NTLA | Maintain | Market Outperform (N/A) |
|
Details | ||
| 11/30/2021 | Cellectis | CLLS | New Coverage | Market Outperform (N/A) |
8.69 (2.79) |
-67.89% | Details | |
| 11/16/2021 | LogicBio Therapeutics | LOGC | Maintain | Market Outperform (N/A) |
|
Details | ||
| 11/11/2021 | Taysha Gene Therapies | TSHA | Maintain | Market Outperform (N/A) |
|
Details | ||
| 11/3/2021 | MacroGenics | MGNX | Maintain | Market Outperform (N/A) |
|
Details | ||
| 10/19/2021 | Vor Biopharma, Inc. | VOR | New Coverage | Market Outperform (N/A) |
15.46 (14.48) |
-6.34% | Details | |
| 10/19/2021 | MacroGenics | MGNX | New Coverage | Market Outperform (N/A) |
19.74 (4.78) |
-75.79% | Details | |
| 10/11/2021 | Turning Point Therapeutics Inc. | TPTX | Downgrade | Market Perform (Market Outperform) |
47.76 (76.01) |
59.15% | Details | |
| 6/28/2021 | Intellia Therapeutics | NTLA | Maintain | Market Outperform (N/A) |
|
Details | ||
| 6/23/2021 | Intellia Therapeutics | NTLA | Maintain | Market Outperform (N/A) |
|
Details | ||
| 6/8/2021 | Generation Bio | GBIO | New Coverage | Market Outperform (N/A) |
26.88 (5.34) |
-80.13% | Details | |
| 6/8/2021 | Taysha Gene Therapies | TSHA | New Coverage | Market Outperform (N/A) |
22.32 (6.94) |
-68.91% | Details | |
| 5/6/2021 | Turning Point Therapeutics Inc. | TPTX | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 3/29/2021 | Relay Therapeutics | RLAY | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 3/4/2021 | Intellia Therapeutics | NTLA | New Coverage | Market Outperform (N/A) |
61.97 (15.50) |
-74.99% | Details | |
| 3/4/2021 | LogicBio Therapeutics | LOGC | New Coverage | Market Outperform (N/A) |
8.32 (7.06) |
-15.14% | Details | |
| 3/4/2021 | CRISPR Therapeutics | CRSP | New Coverage | Market Outperform (N/A) |
129.77 (53.55) |
-58.73% | Details | |
| 1/12/2021 | Turning Point Therapeutics Inc. | TPTX | Maintain | Market Outperform (N/A) |
|
Details | ||
| 12/8/2020 | Turning Point Therapeutics Inc. | TPTX | New Coverage | Market Outperform (N/A) |
107.34 (76.01) |
-29.19% | Details | |
| 12/8/2020 | Relay Therapeutics | RLAY | New Coverage | Market Outperform (N/A) |
52.00 (18.02) |
-65.35% | Details | |
| 12/8/2020 | Mirati Therapeutics | MRTX | New Coverage | Market Outperform (N/A) |
233.26 (58.70) |
-74.83% | Details |
